(Q46712866)

24 December 2017

title

Antimutagenic and anti-oxidant activities of the non-steroidal anti-inflammatory drug celecoxib (English)

1 reference

24 December 2017

author name string

Ta Ajith

1

1 reference

24 December 2017

J P Subin

2

1 reference

24 December 2017

J Jacob

3

1 reference

24 December 2017

P S Sanjay

4

1 reference

24 December 2017

N V Babitha

5

1 reference

24 December 2017

publication date

1 October 2005

1 reference

24 December 2017

Clinical and Experimental Pharmacology and Physiology

published in

1 reference

24 December 2017

volume

32

1 reference

24 December 2017

issue

10

1 reference

24 December 2017

page(s)

888-893

1 reference

24 December 2017

A genetic model for colorectal tumorigenesis

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.04280.X

Growth factors and oncogenes in human gastrointestinal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.04280.X

Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.04280.X

Inflammation and free radicals in tumor development and progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.04280.X

Mechanisms and applications of non-steroidal anti-inflammatory drugs in the chemoprevention of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.04280.X

Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.04280.X

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.04280.X

Revised methods for the Salmonella mutagenicity test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.04280.X

Antioxidant and antihepatotoxic activities of Phellinus rimosus (Berk) Pilat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.04280.X

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.04280.X

Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.04280.X

Celecoxib simulates respiratory burst through pertussis toxin-sensitive G-protein, a possible signal for beta 2-integrin expression on human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.04280.X

Activation of stress signaling pathways by the end product of lipid peroxidation. 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.04280.X

10.1111/J.1440-1681.2010.04280.X

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017